S296: IN VITRO ANALYSIS OF THE IMPACT OF INHIBITORS ON THE PROCOAGULANT EFFECTS OF BYPASS AGENTS OR HEMOSTATIC FACTORS IN COMBINATION WITH EMICIZUMAB

S296: IN VITRO ANALYSIS OF THE IMPACT OF INHIBITORS ON THE PROCOAGULANT EFFECTS OF BYPASS AGENTS OR HEMOSTATIC FACTORS IN COMBINATION WITH EMICIZUMAB

Bibliographic Details
Main Authors:	A. Dos Santos Ortas, E. García Arias-Salgado, E. Monzón Manzano, P. Acuña, M. T. Álvarez Roman, M. Martín Salces, M. I. Rivas Pollmar, E. García Pérez, M. Gutiérrez Alvariño, A. Gonzalez Ceberino, S. García Barcenilla, N. Butta, V. Jiménez Yuste
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844076.79194.e5

Similar Items

P1661: THROMBOPATHY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND AUTOIMMUNE DISEASE
by: E. Garcia Perez, et al.
Published: (2022-06-01)

P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
by: E. Monzón Manzano, et al.
Published: (2022-06-01)

P1656: EVALUATION OF PLATELET FUNCTION IN RARE OR UNDIAGNOSED BLEEDING DISORDERS
by: P. Acuña Butta, et al.
Published: (2022-06-01)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
by: Elena Monzón Manzano, et al.
Published: (2020-10-01)

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia
by: Andrés Ramírez-López, et al.
Published: (2021-04-01)

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia
by: María-Teresa Álvarez Román, et al.
Published: (2021-03-01)

P135 Altered hemostatic balance towards procoagulant state in pregnant women with systemic lupus erythematosus
by: Aleksandra Antovic, et al.
Published: (2024-03-01)

P1618: REAL-WORLD DATA ON EMICIZUMAB: CORRELATION BETWEEN DRUG PLASMA LEVELS, GLOBAL PROCOAGULANT STATUS AND SPONTANEOUS JOINT ANNUALIZED BLEEDING RATE
by: Francisco José López Jaime, et al.
Published: (2023-08-01)

BRAZILIAN REGISTRY OF PERSONS WITH HEMOPHILIA A RECEIVING EMICIZUMAB (EMICIZUMAB CASES, EMCASE PROJECT)
by: R.M. Camelo, et al.
Published: (2020-11-01)

Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
by: Hannah Glonnegger, et al.
Published: (2022-08-01)

Enhanced Hemostatic and Procoagulant Efficacy of PEG/ZnO Hydrogels: A Novel Approach in Traumatic Hemorrhage Management
by: Chuyue Zhang, et al.
Published: (2024-01-01)

Emicizumab-induced photosensitivity
by: Pedro Asensi Cantó, et al.
Published: (2022-07-01)

Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome
by: Raisa Guerrero Camacho, et al.
Published: (2022-05-01)

Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020-01-01)

The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
by: Nina Haagenrud Schultz, et al.
Published: (2021-07-01)

Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab
by: Víctor Jiménez-Yuste, et al.
Published: (2024-04-01)

Proteome of endothelial cell-derived procoagulant microparticles.
by: Banfi, C, et al.
Published: (2005)

Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan
by: Naoki Matsumoto, et al.
Published: (2023-07-01)

Emicizumab Associated Rhabdomyolysis in Hemophilia A
by: Joseph A. Wilson, et al.
Published: (2020-10-01)

Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
by: Giancarlo Castaman, et al.
Published: (2024-01-01)

Haemophilia A management with emicizumab: A survey of haematologists in the United States
by: Patel Anisha M., et al.
Published: (2022-03-01)

Modeling and simulation of procoagulant circulating tumor cells in flow
by: Angela eLee, et al.
Published: (2012-09-01)

P1616: EMICIZUMAB FOR THE MANAGEMENT OF ACQUIRED HEMOPHILIA A
by: Meera Sridharan, et al.
Published: (2023-08-01)

Influence of emicizumab on protein C-mediated clotting regulation
by: Federica Mancazzo, et al.
Published: (2023-10-01)

Disruptive technology and hemophilia care: The multiple impacts of emicizumab
by: Cedric Hermans, et al.
Published: (2021-05-01)

Expert opinion paper on the treatment of hemophilia A with emicizumab
by: Francisco-José López-Jaime, et al.
Published: (2023-12-01)

Impact of Epicatechin on the Procoagulant Activities of Microparticles
by: Thomas Sinegre, et al.
Published: (2020-09-01)

Procoagulant constituents from Cordyceps militaris
by: Juanjuan Zhang, et al.
Published: (2018-12-01)

Procoagulant inhibitory properties of paclitaxel poliglumex
by: John Nemunaitis, et al.
Published: (2010-12-01)

Evaluation Procoagulant Activity and Mechanism of Astragalin
by: Changqin Li, et al.
Published: (2020-01-01)

Thyroid dysfunction and the hemostatic system
by: N M Platonova, et al.
Published: (2014-10-01)

296 rahsia facebook /
by: 597754 Hayes, Judy author, et al.
Published: (2011)

Development of coagulation factor probes for the identification of procoagulant circulating tumor cells
by: Garth William Tormoen, et al.
Published: (2012-09-01)

Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
by: Fumiya Inoue, et al.
Published: (2022-03-01)

Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023-04-01)

THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
by: Юлия Олеговна Рождественская, et al.
Published: (2023-02-01)

Management of multiple myeloma in a patient with haemophilia with concurrent emicizumab – case report
by: Davies Elizabeth, et al.
Published: (2021-12-01)

Procoagulant and Antimicrobial Effects of Chitosan in Wound Healing
by: Chih-Hsin Wang, et al.
Published: (2021-06-01)

The procoagulant effects of fine particulate matter <it>in vivo</it>
by: Pitz Mike, et al.
Published: (2011-03-01)

Structural requirements for the procoagulant activity of nucleic acids.
by: Julia Gansler, et al.
Published: (2012-01-01)